# Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam

> **NCT02233244** · PHASE1 · COMPLETED · sponsor: **Celtaxsys, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CTX-4430
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT02233244
- **Lead sponsor:** Celtaxsys, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02233244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02233244, "Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02233244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*